TNFSF10 and cholangiocarcinoma: The independence of Bid or Bim suggested the intriguing possibility that cyclopamine may sensitize cholangiocarcinoma cells to TRAIL by converting apoptotic signaling from a Type II to a Type I death receptor pathway.